文献速递白血病

抑制PHB2/PINK1介导的线粒体自噬增强急性髓系白血病对venetoclax的敏感性

Inhibition of PHB2/PINK1-mediated mitophagy potentiates venetoclax activity in acute myeloid leukemia.
PubMed 文献 · Leukemia · 2026-10-13

该研究探讨PINK1在AML细胞线粒体自噬调控中的作用。结果显示PINK1是线粒体自噬的核心调节因子,PHB2调控线粒体应激时PINK1的稳定。遗传敲低PINK1或PHB2及药物抑制PHB2均显著增加AML细胞对venetoclax的敏感性(体外和体内)。

要点

  • PINK1是AML细胞线粒体自噬的核心调节因子,敲低导致线粒体累积和功能受损。
  • PHB2调控线粒体应激时PINK1的稳定,敲低或抑制PHB2可模拟PINK1缺失的生物学效应。
  • 靶向PHB2/PINK1通路可破坏线粒体自噬,增强venetoclax对AML的疗效。

核心结论

  • 靶向PHB2/PINK1信号通路可通过破坏线粒体自噬过程提高venetoclax为基础疗法在AML中的疗效。

研究设计与样本

  • 研究在AML细胞中探讨PINK1对线粒体自噬的调控作用,采用遗传敲低和药物抑制方法,并进行体外和体内实验验证。

主要发现

  • 遗传敲低PINK1减少基础和应激诱导的线粒体自噬,导致线粒体累积和功能受损。
  • 线粒体应激时PINK1的稳定由PHB2调控,敲低或抑制PHB2可模拟PINK1缺失的生物学效应。
  • 遗传敲低PINK1或PHB2以及药物抑制PHB2均显著增加AML细胞对venetoclax的敏感性(体外和体内)。

临床怎么用

  • 在AML治疗中,可考虑联合抑制PHB2/PINK1通路以增强venetoclax疗效,尚需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute myeloid leukemia (AML) cells are highly dependent on mitochondrial activity for survival, with this metabolic reliance driven in part by BCL-2, which is therapeutically targeted by venetoclax-based therapies. The regulation of mitochondrial dynamics in leukemic cells is therefore essential for maintaining mitochondrial homeostasis. However, the mechanisms that enable selective degradation of damaged mitochondria (mitophagy) are still poorly understood in AML. In this study, we sought to elucidate the role of PTEN-induced putative kinase 1 (PINK1), a key sensor of mitochondrial stress, in regulating mitophagy in leukemic cells. Our results identified PINK1 as a central modulator of mitophagy. Genetic depletion of PINK1 reduced both basal and stress-induced mitophagy, leading to mitochondria accumulation and functional impairment. Additionally, we discovered that PINK1 stabilization during mitochondrial stress is regulated by Prohibitin 2 (PHB2), and that depletion or inhibition of PHB2 mirrored the biological effects of PINK1 loss. Notably, both genetic depletion of PINK1 or PHB2, as well as pharmacological inhibition of PHB2, significantly increased AML cell sensitivity to venetoclax both in vitro and in vivo. Together, these findings highlight the potential of targeting the PHB2/PINK1 signalling pathway to improve the efficacy of venetoclax-based therapies in AML by disrupting the mitophagy process.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Vazquez R, Sajot M, Nasrallah J, et al. Inhibition of PHB2/PINK1-mediated mitophagy potentiates venetoclax activity in acute myeloid leukemia. Leukemia. 2026. PMID: 42869959. doi:10.1038/s41375-026-03160-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。